18:43:51 EDT Thu 16 May 2024
Enter Symbol
or Name
USA
CA



Principal Technologies Inc
Symbol PTEC
Shares Issued 22,875,461
Close 2023-08-17 C$ 0.15
Market Cap C$ 3,431,319
Recent Sedar Documents

Principal Technologies boasts of advisory board

2023-08-22 12:07 ET - News Release

Mr. Jerry Trent reports

PRINCIPAL TECHNOLOGIES FINAL REBRAND AND STRENGTHENS ADVISORY BOARD

Principal Technologies Inc. has provided a corporate update to shareholders, and has updated and upgraded its website to better reflect the strategic focus of the company.

Principal's focus is to capitalize on arbitrage situations by acquiring health care technology companies with proven and leading technologies in the European Union (EU), expanding sales globally, and taking advantage of the higher valuations in North America.

The company plans to acquire a substantial private health care technology company within 12 months, which will transform Principal, and provide a platform for future growth and profitability.

The company has access to both acquisition targets and significant EU capital through its high-profile management team and advisers. Key people include:

  • Jerry Trent -- president, chief executive officer and director:
    • Mr. Trent is the founder of Trent Investments, a multifamily direct investment agency for European ultrahigh-net-worth individuals and asset management funds. In Europe, he served as the head of global markets and investment banking at SberBank, as well as the head of M&A (mergers and acquisitions), and member of the global deals origination group at PricewaterhouseCoopers. Mr. Trent's experience also includes being a successful Wall Street investor and portfolio manager.
  • Prince Alfred of Liechtenstein -- chairman, board of directors:
    • Prince Alfred of Liechtenstein has served on numerous boards and in several supervisory positions, including at LGT Group (the largest family-owned asset management group globally). He holds a master's degree in economics and informatics, and has authored numerous books and articles on a wide range of topics. Prince Alfred is also the chairman of the advisory board of the International Peace Foundation, of which 19 advisers are Nobel Prize Laureates, including four in the medical field. Prince Alfred has also received multiple awards and prizes for his health care initiatives and humanitarian activity.
  • Dr. Leopold Specht -- director:
    • Dr. Specht is a veteran attorney with extensive investment experience. He is the owner of international corporate law firm Specht & Partner. In addition to serving on numerous boards, he is a member of the Economic Council at Harvard Institute for Global Law at Harvard Law School. Widely renowned for his expertise, Dr. Specht regularly serves as a guest lecturer at institutions such as Harvard University, Brown University, the University of Turin and the University of Sapienza Rome.
  • Dr. Gerald Rainer -- chairman, board of advisers:
    • Dr. Rainer is the former CEO of Julius Baer, a $400-billion (U.S.) asset management company in Switzerland. He has also served as a board member and trustee of several large international organizations. His impressive business acumen and extensive international network have allowed him to also thrive as a serial entrepreneur.
  • Dr. Ivo Ivanovski -- board of advisers:
    • Dr. Ivanovski served as the IT (information technology) Minister of the Republic of Macedonia from 2006 to 2015. He then entered the private sector as head of mergers and acquisitions, international affairs and regulations, at A1 Telekom Austria Group, where he now serves as the CEO of the exchange-listed Tower Co. Dr. Ivanovski has received multiple awards over the course of his career, including the International Telecommunication Union's Distinguished Silver Star Award and an honorary doctorate for technology leadership.
  • Rick Geoffrion -- board of advisers:
    • Mr. Geoffrion has been president and CEO of multiple health care technology companies that have developed proprietary systems to significantly improve patient outcomes. Over the course of his 35-year career, Mr. Geoffrion has also served in board positions at numerous health care technology companies. Currently, he is vice-chairman of the Mullings Group, a leading career development firm focused on the health care sector.
  • Peter McKeown -- chief financial officer:
    • A seasoned finance and business professional, Mr. McKeown has founded and served in executive positions at multiple successful Canadian public companies. Armed with decades of experience, Mr. McKeown is a serial entrepreneur focused on the technology and resource sectors. He is a CPA and obtained a BComm from Carleton University.

The company has made a few strategic acquisitions to date, primarily made to provide a technical due diligence team based in the EU and also to substantiate the valuation model.

E&E CRO Consulting GmbH

An 80-per-cent-owned clinical research organization (CRO), E&E facilitates the international distribution permits process for health care technology companies. This strategic investment will allow Principal to build a unique database which it will leverage to improve patient outcomes, serve the industry (hospitals, insurers and other stakeholders seeking medical information), as well as find new acquisition targets for its international rollout process. Based in the EU, E&E is a cash-flow-positive company with stable revenue and a highly experienced in-house technical due diligence team.

Vision Surgery AI

A minor equity investment with the capacity for expanded ownership as operations increase, Vision uses advanced computer vision and artificial intelligence technology for real-time monitoring of surgical teams and operating room equipment. Its technology detects and sends alerts about any anomaly or deviation from typical surgical procedures, significantly reducing complications and fatalities. Vision's technology also leverages collected observations to build a database of medical information for machine learning purposes. Given that roughly 80 per cent of surgical fatalities stem from human error, Vision has the potential to considerably improve surgical outcomes.

The company is now fully operational and pursuing its strategic focus. In the next 12 months, it plans to acquire a substantial private health care technology company, which will transform Principal and provide a platform for future growth and profitability.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.